Clinical Trial Update: Evaluate the Safety, Tolerability, Biodistribution Characteristics and Preliminary Efficacy of BioTTT001 [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating BioTTT001 for safety, tolerability, biodistribution, and preliminary efficacy in leptomeningeal metastasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leptomeningeal Metastasis

Drugs mentioned

• BioTTT001

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Meningeal Metastasis | Phase 1, Phase 2 | Status: RECRUITING